CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...